Advanced search
Publication Cover
Journal of Inflammation Research Volume 14, 2021 - Issue
Submit an article Journal homepage
115
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease

Qiongrong Huang1 Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350108, Fujian Province, People’s Republic of China;2 CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, People’s Republic of ChinaView further author information
,
Xiuli Zhang2 CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Zhiyuan Hu1 Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350108, Fujian Province, People’s Republic of China;2 CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, People’s Republic of China;3 School of Nanoscience and Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 100049, People’s Republic of China;4 School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, 430205, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 1933-1943 | Published online: 14 May 2021

References

  • Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi:10.1038/nrgastro.2015.150
  • Sexton KA, Walker JR, Targownik LE, et al. The inflammatory bowel disease symptom inventory: a patient-report scale for research and clinical application. Inflamm Bowel Dis. 2019;25(8):1277–1290. doi:10.1093/ibd/izz038
  • Kinsey L, Burden S. A survey of people with inflammatory bowel disease to investigate their views of food and nutritional issues. Eur J Clin Nutr. 2016;70(7):852–854. doi:10.1038/ejcn.2016.57
  • Lloyd-Price J, Arze C, Ananthakrishnan AN, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9
  • Lamb CA, Kennedy NA, Raine T, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106. doi:10.1136/gutjnl-2019-318484
  • Mossotto E, Ashton JJ, Coelho T, Beattie RM, MacArthur BD, Ennis S. Classification of paediatric inflammatory bowel disease using machine learning. Sci Rep. 2017;7(1):2427. doi:10.1038/s41598-017-02606-2
  • Ozawa T, Ishihara S, Fujishiro M, et al. Novel computer-assisted diagnosis system for endoscopic disease activity in patients with ulcerative colitis. Gastrointest Endosc. 2019;89(2):416–421 e1. doi:10.1016/j.gie.2018.10.020
  • Franzosa EA, Sirota-Madi A, Avila-Pacheco J, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4(2):293–305. doi:10.1038/s41564-018-0306-4
  • Oussalah A, Gueant JL, Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther. 2011;34(10):1173–1184. doi:10.1111/j.1365-2036.2011.04864.x
  • Sangshetti JN, Khan FA, Shinde DB. Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery. Curr Med Chem. 2015;22(2):214–236. doi:10.2174/0929867321666140826115734
  • Leeds JA, Dean CR. Peptide deformylase as an antibacterial target: a critical assessment. Curr Opin Pharmacol. 2006;6(5):445–452. doi:10.1016/j.coph.2006.06.003
  • Proteau PJ. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview. Bioorg Chem. 2004;32(6):483–493. doi:10.1016/j.bioorg.2004.08.004
  • Singh N, Cheve G, Avery MA, McCurdy CR. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme. Curr Pharm Des. 2007;13(11):1161–1177. doi:10.2174/138161207780618939
  • Serrano A, Ferreira P, Martinez-Julvez M, Medina M. The prokaryotic FAD synthetase family: a potential drug target. Curr Pharm Des. 2013;19(14):2637–2648. doi:10.2174/1381612811319140013
  • Gnainsky Y, Zfanya N, Elgart M, et al. Systemic regulation of host energy and oogenesis by microbiome-derived mitochondrial coenzymes. Cell Rep. 2021;34(1):108583. doi:10.1016/j.celrep.2020.108583
  • Kukko E, Saarento H. Diphosphate concentration does not correlate with the level of inorganic diphosphatase in Escherichia coli. Folia Microbiol (Praha). 1984;29(4):282–287. doi:10.1007/BF02875958
  • Vincent EE, Sergushichev A, Griss T, et al. Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth. Mol Cell. 2015;60(2):195–207. doi:10.1016/j.molcel.2015.08.013
  • Hornik K, Stinchcombe M, White H. Multilayer feedforward networks are universal approximators. Neural Netw. 1989;2(5):359–366. doi:10.1016/0893-6080(89)90020-8

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.